Our Partnerships

After we identify and develop assets to key value inflection points, Optimvia seeks to partner with a variety of firms to get those assets to patients in need. Our first partnership is with Ginkgo Bioworks to bring our heparin technology to commercial scale manufacturing.

Ginkgo Bioworks

Optimvia has recently partnered with Ginkgo Bioworks, the leading horizontal platform for cell programming, to improve the manufacturing efficiency of our biosynthetic heparin technology.

With this partnership, we aim to scale our technology to economically meet the global heparin demand, and remove slaughtered animals from the equation entirely.